Area of research
Immunology · Oncology
Research interest
Research interests include Immune Cell Function and Interaction, Immunotherapy and Immune Responses, Cancer Immunotherapy and Biomarkers, and Multiple Myeloma Research and Treatments.
Cyto-IL-15 synergizes with the STING agonist ADU-S100 to eliminate prostate tumors and confer durable immunity in mouse models
IL-15 Upregulates Telomerase Expression and Potently Increases Proliferative Capacity of NK, NKT-Like, and CD8 T Cells
Combination of Interleukin-15 With a STING Agonist, ADU-S100 Analog: A Potential Immunotherapy for Prostate Cancer
Prostate cancer cells enhance interleukin‐15‐mediated expansion of NK cells
HES1 in immunity and cancer
Extending the lifespan and efficacies of immune cells used in adoptive transfer for cancer immunotherapies–A review
Enhanced cross‐priming of naive <scp>CD</scp>8<sup>+</sup><scp>T</scp> cells by dendritic cells treated by the <scp>IM</scp>i<scp>D</scp>s<sup>®</sup> immunomodulatory compounds lenalidomide and pomalidomide
BAUS Section of Academic Urology Oral Abstracts